BORGWARNER INC
For the period ended Mar 31, 2024. Filed May 2, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 2, 2024
BWA$48.81+2.7%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023 (Unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| (in millions) | March 31,2024 | December 31,2023 |
|---|---|---|
| ASSETS | ||
| Cash, cash equivalents and restricted cash | $1,037 | $1,534 |
| Receivables, net | 3,289 | 3,109 |
| Inventories, net | 1,333 | 1,313 |
| Prepayments and other current assets | 298 | 261 |
| Total current assets | 5,957 | 6,217 |
| Property, plant and equipment, net | 3,766 | 3,783 |
| Investments and long-term receivables | 365 | 364 |
| Goodwill | 2,977 | 3,013 |
| Other intangible assets, net | 540 | 564 |
| Other non-current assets | 517 | 512 |
| Total assets | $14,122 | $14,453 |
| LIABILITIES AND EQUITY | ||
| Short-term debt | $445 | $73 |
| Accounts payable | 2,378 | 2,546 |
| Other current liabilities | 1,046 | 1,148 |
| Total current liabilities | 3,869 | 3,767 |
| Long-term debt | 3,295 | 3,707 |
| Retirement-related liabilities | 142 | 146 |
| Other non-current liabilities | 774 | 767 |
| Total liabilities | 8,080 | 8,387 |
| Commitments and contingencies | ||
| Common stock | 3 | 3 |
| Capital in excess of par value | 2,632 | 2,689 |
| Retained earnings | 6,325 | 6,152 |
| Accumulated other comprehensive loss | (883) | (828) |
| Common stock held in treasury, at cost | (2,236) | (2,188) |
| Total BorgWarner Inc. stockholders’ equity | 5,841 | 5,828 |
| Noncontrolling interest | 201 | 238 |
| Total equity | 6,042 | 6,066 |
| Total liabilities and equity | $14,122 | $14,453 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.